Massively parallel de novo protein design for targeted therapeutics
暂无分享,去创建一个
Lu Zhang | Xuhui Huang | David Baker | Inna Goreshnik | Aaron Chevalier | Daniel-Adriano Silva | Ian A Wilson | Christopher D Bahl | Lance Stewart | Gabriel J Rocklin | Derrick R Hicks | Renan Vergara | Patience Murapa | Steffen M Bernard | Kwok-Ho Lam | Guorui Yao | Shin-Ichiro Miyashita | James T Fuller | Merika T Koday | Cody M Jenkins | Tom Colvin | Lauren Carter | Alan Bohn | Cassie M Bryan | D Alejandro Fernández-Velasco | Min Dong | Rongsheng Jin | Deborah H Fuller | D. Baker | Daniel‐Adriano Silva | I. Wilson | Xuhui Huang | G. Rocklin | Inna Goreshnik | L. Carter | A. Chevalier | L. Stewart | C. Bahl | K. Lam | D. A. Fernández‐Velasco | S. Bernard | A. Bohn | D. Fuller | Patience Murapa | Lu Zhang | Derrick R. Hicks | R. Jin | C. Bryan | J. Fuller | G. Yao | R. Vergara | Shin-Ichiro Miyashita | M. Dong | M. T. Koday | Cody M Jenkins | Merika T. Koday | Tom Colvin | D. Baker | Rongsheng Jin | Alejandro D. Fernández‐Velasco | D. Baker
[1] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[2] Timothy A. Whitehead,et al. Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin , 2011, Science.
[3] Vincent B. Chen,et al. Correspondence e-mail: , 2000 .
[4] L. Benatuil,et al. An improved yeast transformation method for the generation of very large human antibody libraries. , 2010, Protein engineering, design & selection : PEDS.
[5] Tri Giang Phan,et al. Challenges and opportunities for non-antibody scaffold drugs. , 2015, Drug discovery today.
[6] Jiajie Zhang,et al. PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..
[7] S. Nosé,et al. Constant pressure molecular dynamics for molecular systems , 1983 .
[8] Andreas Plückthun,et al. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size. , 2010, Cancer research.
[9] Alan Bye,et al. Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers , 1999, Clinical pharmacokinetics.
[10] G. Watson,et al. Computer simulation , 1988 .
[11] Nathaniel Echols,et al. The Phenix software for automated determination of macromolecular structures. , 2011, Methods.
[12] David Baker,et al. A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells , 2014, Cell.
[13] A. Brünger. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures , 1992, Nature.
[14] L. Murr,et al. Computer Simulation in Materials Science and Engineering , 2015 .
[15] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[16] Min Dong,et al. Structure of Botulinum neurotoxin B binding domain in complex with both synaptotagmin II and GD1a , 2013 .
[17] Timothy A. Whitehead,et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing , 2012, Nature Biotechnology.
[18] D. Hoover,et al. DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. , 2002, Nucleic acids research.
[19] Jennifer R Cochran,et al. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles. , 2016, Current opinion in chemical biology.
[20] Michaela Gebauer,et al. Engineered protein scaffolds as next-generation antibody therapeutics. , 2009, Current opinion in chemical biology.
[21] D. Baker,et al. RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design , 2011, PloS one.
[22] N. Koga,et al. Principles for Designing Ideal Protein Structures , 2013 .
[23] Michael J MacCoss,et al. Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer , 2016, eLife.
[24] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[25] D. Baker,et al. Global analysis of protein folding using massively parallel design, synthesis, and testing , 2017, Science.
[26] Axel T. Brunger,et al. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity , 2006, Nature.
[27] David Baker,et al. Removing T-cell epitopes with computational protein design , 2014, Proceedings of the National Academy of Sciences.
[28] D. Baker,et al. Control over overall shape and size in de novo designed proteins , 2015, Proceedings of the National Academy of Sciences.
[29] D. J. Stevens,et al. The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin , 2004, Science.
[30] M. Parrinello,et al. Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.
[31] Daniel-Adriano Silva,et al. Motif-Driven Design of Protein-Protein Interfaces. , 2016, Methods in molecular biology.
[32] J. Skehel,et al. A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.
[33] Maria Zambon,et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. , 2012, The Lancet. Infectious diseases.
[34] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[35] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[36] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[37] Jens Meiler,et al. RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite , 2011, PloS one.
[38] D. Baker,et al. Principles for designing ideal protein structures , 2012, Nature.
[39] David Baker,et al. A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response , 2016, PLoS pathogens.
[40] A. Blitzer,et al. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series , 2010, European journal of neurology.
[41] R. Dror,et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.
[42] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[43] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[44] Patrick J. Paddison,et al. Production of complex nucleic acid libraries using highly parallel in situ oligonucleotide synthesis , 2004, Nature Methods.
[45] Philip M. Kim,et al. Protein engineering by highly parallel screening of computationally designed variants , 2016, Science Advances.
[46] K Dane Wittrup,et al. Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.
[47] David Baker,et al. Accurate de novo design of hyperstable constrained peptides , 2016, Nature.
[48] B. Kuhlman,et al. SwiftLib: rapid degenerate-codon-library optimization through dynamic programming , 2014, Nucleic acids research.
[49] Jaap Heringa,et al. PRALINE: a versatile multiple sequence alignment toolkit. , 2014, Methods in molecular biology.